Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
With
GlaxoSmithKline
Age
50–85
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
post-menopausal women, 50-85 years of age;
any inflammatory rheumatoid disease including polymyalgia rheumatica;
receiving treatment with 5-15 mg/day of prednisolone.
You may not be if
previous treatment with an iv bisphosphonate at any time;
previous treatment with an oral bisphosphonate within the last 6 months, \>1 month of treatment within last year, or \>3 months of treatment within last 2 years;
treatment with parathyroid hormone in last 2 years;
inability to stand or sit in an upright position for at least 60 minutes;
inability to swallow a tablet whole;
history of major gastrointestinal disease.
Clareo Health | A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.
